Study of Application of Tilashtaka Ghrita in the Treatment of Dushta Avastha of Vrana

"A RANDOMIZED,CONTROLLED,CLINICAL STUDY OF EFFICACY OF LOCAL APPLICATION OF TILASHTAK GHRITA IN MANAGEMENT OF DUSHTA AVASTHA OF VRANA WITH SPECIAL REFERENCE TO INFECTED WOUND."

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028187

Enrollment

Registered

2020-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Tilashtak Ghrita: Under All Aseptic Precautions Local Application Of Tilashtak Ghrita Once Daily For 14 Day Control Intervention1: Povidone Iodine Ointment And Combination Of Tablet Cef

Eligibility

Inclusion criteria

Inclusion criteria: Wound length 3 to 15 cm Patients with fulfilled screening criteria Wounds up to muscle

Exclusion criteria

Exclusion criteria: Patients suffering from major illness like cirrhosis liver disorder or Ascitis or Renal Failure or DM or Tuberculosis or AIDS or HIV syndrome Patient with malignancy Bleeding Disorder Multiple Ulcer(more than three) Arterial Ulcers T.A.O. Leprotic ulcers Gonorrheal ulcers Syphilitic ulcers Vranas situated over Asthi and Sandhi and Koshta and Marma Adhisthana Age Group 60 years old

Design outcomes

Primary

Measure	Time frame
To find out the efficacy of Tilashtak Ghrita in decreasing healing time of Dushta Avastha of vranaTimepoint: 14 days	—

Secondary

Measure	Time frame
To compare the effects of local application of Tilashtak ghrita and povidone iodine ointment in dushta avastha of vrana To Standardize Tilashtak ghrita Timepoint: 14 days	—

Countries

India

Contacts

Public ContactVd Ramesh B Jadhav

Government Ayurved College And Hospital Nanded

ms.rameshjadhav82@gmail.com9404857689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026